CClinicalTrials.gg
CompletedNCT05563194JIA ToolboxUpdated Jun 8, 2023

Proof-of-concept Study of 'JIA Toolbox' for Children and Young People (CYP) With Juvenile Idiopathic Arthritis (JIA)

An interventional study of Heating prototype (Prototype 1) and Physio tool (Prototype 2) in Rheumatologic Disease, sponsored by Sheffield Children's NHS Foundation Trust. Completed at 1 site in United Kingdom. Open to participants aged 7 Years to 16 Years. Per ClinicalTrials.gov, last updated 2023-06-08.

Sponsored by Sheffield Children's NHS Foundation Trust · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
10
Allocation
Not applicable
Ages
7 Years to 16 Years
Sex
All
01

Study summary

This project aims to further develop and conduct a 'real-world' proof-of-concept assessment of a suite of three products, known as the 'JIA Toolbox', that collectively aim to improve CYP's independence and functional ability

'JIA Toolbox' targets key unmet needs identified by stakeholders during our previous work. Each prototype (Appendix1) addresses a specific unmet need:

  1. Prototype-1: Pain which stops CYP doing the things they love;
  2. Prototype-2: Difficulty for healthcare professionals (HCPs) to motivate CYP to do stretches;
  3. Prototype-3: Communication difficulties between teachers and CYP

The project is at a stage where the prototypes need their potential value assessed through a proof-of-concept study. A co-design approach, involving CYP with JIA, their parents, their teachers and HCPs, will be maintained throughout to ensure the outcomes are meaningful. This study will begin with co-design workshops to develop the current prototypes further, followed by a qualitative study assessing the real-world usability, acceptability and potential impacts of these prototypes; testing them with real users in their homes. The project aims to make a positive contribution to CYP with JIA by improving their independence and functional ability through co-designed therapeutic interventions.

Read the detailed description

Juvenile Idiopathic Arthritis (JIA) is a long-term rheumatic disease affecting approximately 15,000 children and young people (CYP) in the UK [1] with 1,000-1,500 new diagnoses/year. JIA causes ongoing/long-term joint inflammation, pain, and stiffness, making everyday activities difficult. JIA has been shown to impact physical, social, emotional, and educational development. Products exist to aid tasks such as writing, washing, and eating. However, a survey we conducted in 2018 showed that CYP with JIA find these products difficult to use, stigmatising, and patronising. Furthermore, these products often neglect to consider the wider stakeholder network and how their support, or lack of it, impacts the child's overall wellbeing.

This project aims to further develop and conduct a 'real-world' proof-of-concept assessment of a suite of three products, known as the 'JIA Toolbox', that collectively aim to improve CYP's independence and functional ability

'JIA Toolbox' targets key unmet needs identified by stakeholders during our previous work. Each prototype (Appendix1) addresses a specific unmet need:

  1. Prototype-1: Pain which stops CYP doing the things they love;
  2. Prototype-2: Difficulty for healthcare professionals (HCPs) to motivate CYP to do stretches;
  3. Prototype-3: Communication difficulties between teachers and CYP

The project is at a stage where the prototypes need their potential value assessed through a proof-of-concept study. A co-design approach, involving CYP with JIA, their parents, their teachers and HCPs, will be maintained throughout to ensure the outcomes are meaningful. This study will begin with co-design workshops to develop the current prototypes further, followed by a qualitative study assessing the real-world usability, acceptability and potential impacts of these prototypes; testing them with real users in their homes. The project aims to make a positive contribution to CYP with JIA by improving their independence and functional ability through co-designed therapeutic interventions.

02

Conditions studied

03

In context

Arthritis, Juvenile

352 studies on the registry are indexed under Arthritis, Juvenile; 92 are open to participants now.

This study's enrollment of 10 is below the median of 50 across 225 interventional studies indexed under Arthritis, Juvenile.

Browse Arthritis, Juvenile studies →

Lead sponsor

Sheffield Children's NHS Foundation Trust is the lead sponsor of 51 studies on the registry; 9 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
7 Years to 16 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Aged 7- 16 years (minimum age is 7 to ensure participants can adequately engage with the prototypes and describe their experience)
  • Diagnosis of JIA
  • Currently managed within SCH Rheumatology Service
  • Fluent in verbal and written English
  • Access to a computer with an internet connection to facilitate virtual co-design workshops due to the COVID-19 pandemic

Exclusion criteria

Exclusion Criteria:

  • Aged \<7 years or >16 years
  • Non-fluent in verbal and written English
  • Diagnosis of autistic spectrum disorder (ASD)
  • Children with medically unexplained pain, pain amplification syndromes or other pain disorder
  • Co-existing joint or muscle disorder other than JIA
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
10 participants (actual)

Study arms

  • Experimental
    Children and young people with a diagnosis of Juvenile Idiopathic arthritis

    Single arm study where all participants will receive the three prototype interventions.

    Device: Heating prototype (Prototype 1) · Device: Physio tool (Prototype 2) · Device: Communication tool (Prototype 3)

Interventions

  • DeviceHeating prototype (Prototype 1)

    A wearable that heats and vibrates to help distract from pain. It can be wrapped around any joint with temperature and vibration settings allowing CYP to set the device to their needs.

  • DevicePhysio tool (Prototype 2)

    A motivational physiotherapy tool that incrementally lights up as the CYP do their prescribed stretches, emphasising a sense of progression and making it a more engaging activity.

  • DeviceCommunication tool (Prototype 3)

    A wearable to help communication in the classroom between the teacher and pupil. The child can alert the teacher if they need help, through vibration, without attracting the attention of their classmates, reducing embarrassment.

06

What researchers measure

Primary outcomes

  1. Change in self-management of JIA

    Changes in the participants ability to self-manage their condition independently and confidently. Assessed through daily questionnaires throughout the duration of the study, data (frequency of use, settings chosen) from the prototypes, and a post-intervention interview with participants.

    Time frame: Baseline, Week 9

  2. Change in functional ability

    Changes in ability across physical, emotional, social and educational spheres. Assessed through daily questionnaires throughout the duration of the study, data (frequency of use, settings chosen) from the prototypes, and a post-intervention interview with participants.

    Time frame: Baseline, Week 9

  3. Change in physio adherence

    Change in frequency of participants undertaking recommended physio stretches. Assessed through daily questionnaires throughout the duration of the study, data (frequency of use, settings chosen) from the prototypes, and a post-intervention interview with participants

    Time frame: Baseline, Week 9

  4. Change in pain-management

    Change in participants ability to manage joint pain during a flare up using prototype 1. Assessed through daily questionnaires throughout the duration of the study, data on prototype 1 (frequency of use, settings chosen), and a post-intervention interview with participants.

    Time frame: Baseline, Week 9

07

Study locations

1 site
  • Sheffield Children's NHS Foundation Trust
    Sheffield, S10 2TH, United Kingdom
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 8, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05563194
Lead sponsor
Sheffield Children's NHS Foundation Trust
Responsible party
Sponsor
First posted
Oct 3, 2022
Start date
Aug 15, 2022
Primary completion
Feb 15, 2023
Completion
Mar 31, 2023
Last update
Jun 8, 2023

Study contacts

Ursula Ankeny
study director · Sheffiled Hallam University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion